Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
This study is currently recruiting participants.
Verified January 2013 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Memorial Sloan-Kettering Cancer Center
Collaborators:
Cancer Support Community
CHARLES B WANG COMMUNITY HEALTH CENTER
Queens Health Network
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01632956
First received: June 29, 2012
Last updated: January 3, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
There are few breast cancer support groups that focus on the specific needs of Chinese women. The purpose of this study is to learn about two different ways of providing support groups to help women of Chinese descent cope with the difficulties of a diagnosis of breast cancer and its treatment. The investigators want to learn about how best to support Chinese women with breast cancer by providing two different types of groups: an in-person support group and a virtual (online/phone) support group.
| Condition | Intervention |
|---|---|
|
Chinese Immigrants With Breast Cancer |
Behavioral: in-person support group Behavioral: virtual support group |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study |
Resource links provided by NLM:
Further study details as provided by Memorial Sloan-Kettering Cancer Center:
Primary Outcome Measures:
- feasibility [ Time Frame: 1 year ] [ Designated as safety issue: No ]To pilot and evaluate the feasibility of information-based, culturally-tailored in-person and virtual support groups for Chinese patients with breast cancer. The feasibility of participation in the in-person and virtual support groups will be measured by documenting patient accrual to the pilot study and attendance at the support groups.
Secondary Outcome Measures:
- To compare the impact of participation [ Time Frame: 1 year ] [ Designated as safety issue: No ]in the in-person versus virtual support groups on quality of life (QOL), pain, psychosocial outcomes (distress, depression, anxiety, self-efficacy in coping with cancer), and perceived social support. These outcomes will be measured through a baseline and exit Outcomes Survey.
- To assess satisfaction with the support groups [ Time Frame: 1 year ] [ Designated as safety issue: No ]All participants will complete the Brief Support Group Survey at the end of each support meeting to assess satisfaction with and to provide feedback on the usefulness of the meeting and the information presented, ease of understanding and cultural appropriateness of the information, effectiveness of the facilitator, and suggestions for change or improvement.
- To assess Internet use [ Time Frame: 1 year ] [ Designated as safety issue: No ]among support group participants. All patients approached for study participation will complete the Screening Tool, which includes questions related to Internet use. The Screening Tool will be used for all eligible patients (patients refusing to participate will still be asked to complete the screening tool).
| Estimated Enrollment: | 16 |
| Study Start Date: | June 2012 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
in-person support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
|
Behavioral: in-person support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
|
|
virtual support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
|
Behavioral: virtual support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
|
Eligibility| Ages Eligible for Study: | 21 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Recruitment will be conducted by the MSKCC Research Study Assistant (RSA) with the assistance of the treatment team and community partners. Patients of MSKCC and QCC will be approached in clinic waiting rooms by the RSA. ACS Asian Initiatives and the Charles B Wang Community Health Center are referral sites for this study.
Criteria
Inclusion Criteria:
- Female
- Non-US born
- Resident in the US < 20 years
- Of Chinese descent
- Age 21 years through 80 years
- Language spoken: Mandarin
Diagnosis of breast cancer within 3 months prior to recruitment
*Not required that breast cancer is the patients' first and/or only cancer diagnosis
- Currently receiving cancer treatment;
- Will be living continuously in the US for the next year
- Has a telephone that he/she is willing to use for the study
Exclusion Criteria:
- Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection
- Another household member is already enrolled.
- Prior participation in a cancer support group
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01632956
Contacts
| Contact: Jennifer Leng, MD, MPH | 646-888-4243 | |
| Contact: Francesca Gany, MD, MS | 646-888-4240 |
Locations
| United States, New York | |
| Queens Cancer Center of Queens Hospital | Not yet recruiting |
| Jamaica, New York, United States, 11432 | |
| Contact: Margaret Kemeny, MD 718-883-4031 | |
| Memorial Sloan-Kettering Cancer Center | Recruiting |
| New York, New York, United States, 10065 | |
| Contact: Jennifer Leng, MD, MPH 646-888-4243 | |
| Contact: Francesca Gany, MD, MS 646-888-4240 | |
| Principal Investigator: Jennifer Leng, MD, MPH | |
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Cancer Support Community
CHARLES B WANG COMMUNITY HEALTH CENTER
Queens Health Network
Investigators
| Principal Investigator: | Jennifer Leng, MD, MPH | Memorial Sloan-Kettering Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | Memorial Sloan-Kettering Cancer Center |
| ClinicalTrials.gov Identifier: | NCT01632956 History of Changes |
| Other Study ID Numbers: | 12-105 |
| Study First Received: | June 29, 2012 |
| Last Updated: | January 3, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Memorial Sloan-Kettering Cancer Center:
|
Support Groups Breast cancer Mandarin speaking 12-105 |
Additional relevant MeSH terms:
|
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |
ClinicalTrials.gov processed this record on June 17, 2013